Chemoprevention of superficial bladder cancer

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Abstract

The American Cancer Society estimates that 57,400 new cases of bladder cancer will be diagnosed in the USA in 2003 and that approximately 70% of these cases will be superficial bladder tumors. Due to the high risk of recurrence, patients with superficial bladder cancer represent an ideal group for chemoprevention. Intravesical chemotherapy or immunotherapy is often administered in an attempt to prevent tumor recurrence in high-risk patients, although it is not without toxicity. A large body of evidence links diet and nutrition with bladder cancer. This review summarizes the efficacy of natural and synthetic agents that have purported chemopreventive activity.

Original languageEnglish (US)
Pages (from-to)799-808
Number of pages10
JournalExpert review of anticancer therapy
Volume3
Issue number6
DOIs
StatePublished - Dec 2003

Keywords

  • Bladder cancer
  • Chemoprevention
  • Garlic
  • Green tea
  • Nonsteroidal anti-inflammatory drugs
  • Pyridoxine
  • Selenium
  • Soy
  • Vitamin A
  • Vitamin C

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Chemoprevention of superficial bladder cancer'. Together they form a unique fingerprint.

Cite this